What is LEDIPASVIR & SOFOSBUVIR HEPCINAT LP?
LEDIPASVIR & SOFOSBUVIR HEPCINAT LP Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.
How can be used LEDIPASVIR & SOFOSBUVIR HEPCINAT LP?
Hepcinat-LP Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results.
Sides effects of LEDIPASVIR & SOFOSBUVIR HEPCINAT LP:
The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.
Ledipasvir/sofosbuvir, sold under the trademark Harvoni among others, is a medicine used to treat hepatitis C. It is a fixed-portion mix of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in individuals contaminated with hepatitis C infection (HCV) genotype 1. Some proof additionally upholds use in HCV genotype 3 and 4. It is taken day by day by mouth for 8–24 weeks. Ledipasvir works by diminishing the movement of NS5A and sofosbuvir works by diminishing the action of NS5B polymerase.
Ledipasvir/sofosbuvir was supported for clinical use in the United States, in the European Union, and in Canada in 2014. It is on the World Health Organization’s List of Essential Medicines. For more details click here.
Trade Name:– HEPCINAT LP
Manufacturer: NATCO
Presentation: Tablet
